Financials • Life Insurance
$1.13 ▼ -0.01
(-0.88%)
MKT CAP: $23.0M • VOL: 49.9K
52W L $1 52W H $3
ROARABLE / RQD
D+ • 53/100
PIOTROSKI
6 / 9
AAME // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $210.4M | $188.1M | $186.8M |
| YoY Revenue Growth % | +11.9% | +0.7% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $3.7M | -$1.3M | $1.5M |
| Operating Margin % | 1.8% | -0.7% | 0.8% |
| Net Income (GAAP) | $6.0M | -$1.4M | -$171.0K |
| EBITDA (Normalized) | $4.1M | -$1.1M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $32.9M | $4.8M | $2.6M |
| Capital Expenditures (CapEx) | $466.0K | $225.0K | — |
| Free Cash Flow (FCF) | $32.4M | $4.6M | $2.6M |
| FCF Margin % | 15.4% | 2.4% | 1.4% |
| Return on Invested Capital (ROIC %) | 3.8% | -1.4% | — |
| Cash & Short-Term Equivalents | $43.6M | $35.6M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $120.8M | $110.6M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR AAME.